Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ron Ram, MD is a hematologist in Seattle, Washington.
Clinical Trials
- Telomerase Activity as a Marker For Mobilization Quality Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 2 citationsAddition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interven...Ron Ram, Odelia Amit, Chava Perry, Yair Herishanu, Irit Avivi
Transplantation and Cellular Therapy. 2024-12-01 - 3 citationsListeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Contro...Dina Averbuch, Gloria Tridello, Lotus Wendel, Maija Itälä-Remes, Ilana Oren
Transplantation and Cellular Therapy. 2024-07-01 - Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality.Ido Brami, Tsila Zuckerman, Ron Ram, Batia Avni, Galit Peretz
International Journal of Molecular Sciences. 2023-12-28
Press Mentions
- Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II in an Investigator-Led Phase I/II Chronic Graft vs Host Disease StudyOctober 13th, 2020
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHDNovember 6th, 2017
